Report Content
Chapter 1 Methodology
1.1 Methodology
1.2 Market scope & definitions
1.3 Base estimates & working
1.4 Forecast parameters
1.5 Data validation
1.6 Data sources
1.6.1 Secondary
1.6.1.1 Paid sources
1.6.1.2 Public sources
1.6.2 Primary
Chapter 2 Executive Summary
2.1 Lung cancer industry 360° synopsis, 2018-2032
2.1.1 Business trends
2.1.2 Diagnostics & therapy trends
2.1.3 Indication trends
2.1.4 End-use trends
2.1.5 Regional trends
Chapter 3 Lung Cancer Industry Insights
3.1 Industry segmentation
3.2 Industry landscape, 2018 - 2032
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Rising prevalence of lung cancer globally
3.3.1.2 Several initiatives undertaken by public & private organizations to spread disease awareness
3.3.1.3 Technology advancements
3.3.1.4 Rising demand for minimally invasive procedures
3.3.2 Industry pitfalls & challenges
3.3.2.1 Dearth of well-skilled and trained oncologists and radiologists
3.3.2.2 Risk of complications after biopsy
3.3.2.3 High capital investment coupled with high costs associated with cancer treatment
3.4 Growth potential analysis
3.4.1 By diagnostics & therapy
3.4.2 By indication
3.4.3 By end-use
3.5 COVID-19 impact analysis
3.6 Future market trends
3.7 Technology landscape
3.8 Lung cancer epidemiology
3.9 Regulatory landscape
3.9.1 U.S.
3.9.2 Europe
3.10 Reimbursement scenario
3.11 Porter’s analysis
3.12 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Strategic dashboard
Chapter 5 Lung Cancer Market, By Diagnostics & Therapy
5.1 Key diagnostics & therapy trends
5.2 Diagnostics
5.2.1 Market size, by region, 2018 – 2032 (USD Million)
5.2.2 Bronchoscopy
5.2.2.1 Market size, by region, 2018 – 2032 (USD Million)
5.2.3 TTNA
5.2.3.1 Market size, by region, 2018 – 2032 (USD Million)
5.2.4 Imaging
5.2.4.1 Market size, by region, 2018 – 2032 (USD Million)
5.2.5 Tumor Biomarker Test
5.2.5.1 Market size, by region, 2018 – 2032 (USD Million)
5.2.6 In Situ Hybridization
5.2.6.1 Market size, by region, 2018 – 2032 (USD Million)
5.2.7 Others
5.2.7.1 Market size, by region, 2018 – 2032 (USD Million)
5.3 Therapy
5.3.1 Market size, by region, 2018 – 2032 (USD Million)
5.3.2 Non-invasive
5.3.2.1 Market size, by region, 2018 – 2032 (USD Million)
5.3.2.2 Immunotherapy
5.3.2.2.1 Market size, by region, 2018 – 2032 (USD Million)
5.3.2.3 Targeted therapy
5.3.2.3.1 Market size, by region, 2018 – 2032 (USD Million)
5.3.2.4 Others
5.3.2.4.1 Market size, by region, 2018 – 2032 (USD Million)
5.3.3 Minimally invasive
5.3.3.1 Market size, by region, 2018 – 2032 (USD Million)
5.3.3.2 Radiofrequency ablation
5.3.3.2.1 Market size, by region, 2018 – 2032 (USD Million)
5.3.3.3 Microwave ablation
5.3.3.3.1 Market size, by region, 2018 – 2032 (USD Million)
5.3.3.4 Thermal/cryoablation
5.3.3.4.1 Market size, by region, 2018 – 2032 (USD Million)
5.3.3.5 Others
5.3.3.5.1 Market size, by region, 2018 – 2032 (USD Million)
Chapter 6 Lung Cancer Market, By Indication
6.1 Key indication trend
6.2 Non-small cell lung cancer
6.2.1 Market size, by region, 2018 – 2032 (USD Million)
6.3 Small cell lung cancer
6.3.1 Market size, by region, 2018 – 2032 (USD Million)
Chapter 7 Lung Cancer Market, By End-use
7.1 Key end-use trend
7.2 Hospitals
7.2.1 Market size, by region, 2018 – 2032 (USD Million)
7.3 Diagnostic laboratories
7.3.1 Market size, by region, 2018 – 2032 (USD Million)
7.4 Diagnostic imaging centers
7.4.1 Market size, by region, 2018 – 2032 (USD Million)
7.5 Academia
7.5.1 Market size, by region, 2018 – 2032 (USD Million)
7.6 Specialty clinics
7.6.1 Market size, by region, 2018 – 2032 (USD Million)
7.7 Others
7.7.1 Market size, by region, 2018 – 2032 (USD Million)
Chapter 8 Lung Cancer Market, By Region
8.1 Key regional trends
8.2 North America
8.2.1 Market size, by country, 2018 – 2032 (USD Million)
8.2.2 Market size, by diagnostics & therapy, 2018 – 2032 (USD Million)
8.2.2.1 Market size, by diagnostics, 2018 - 2032 (USD Million)
8.2.2.2 Market size, by therapy, 2018 - 2032 (USD Million)
8.2.2.2.1 Market size, by non-invasive, 2018 - 2032 (USD Million)
8.2.2.2.2 Market size, by minimally invasive, 2018 - 2032 (USD Million)
8.2.3 Market size, by indication, 2018 – 2032 (USD Million)
8.2.4 Market size, by end-use, 2018 – 2032 (USD Million)
8.2.5 U.S.
8.2.5.1 Market size, by diagnostics & therapy, 2018 – 2032 (USD Million)
8.2.5.1.1 Market size, by diagnostics, 2018 - 2032 (USD Million)
8.2.5.1.2 Market size, by therapy, 2018 - 2032 (USD Million)
8.2.5.1.2.1 Market size, by non-invasive, 2018 - 2032 (USD Million)
8.2.5.1.2.2 Market size, by minimally invasive, 2018 - 2032 (USD Million)
8.2.5.2 Market size, by indication, 2018 – 2032 (USD Million)
8.2.5.3 Market size, by end-use, 2018 – 2032 (USD Million)
8.2.6 Canada
8.2.6.1 Market size, by diagnostics & therapy, 2018 – 2032 (USD Million)
8.2.6.1.1 Market size, by diagnostics, 2018 - 2032 (USD Million)
8.2.6.1.2 Market size, by therapy, 2018 - 2032 (USD Million)
8.2.6.1.2.1 Market size, by non-invasive, 2018 - 2032 (USD Million)
8.2.6.1.2.2 Market size, by minimally invasive, 2018 - 2032 (USD Million)
8.2.6.2 Market size, by indication, 2018 – 2032 (USD Million)
8.2.6.3 Market size, by end-use, 2018 – 2032 (USD Million)
8.3 Europe
8.3.1 Market size, by country, 2018 – 2032 (USD Million)
8.3.2 Market size, by diagnostics & therapy, 2018 – 2032 (USD Million)
8.3.2.1 Market size, by diagnostics, 2018 - 2032 (USD Million)
8.3.2.2 Market size, by therapy, 2018 - 2032 (USD Million)
8.3.2.2.1 Market size, by non-invasive, 2018 - 2032 (USD Million)
8.3.2.2.2 Market size, by minimally invasive, 2018 - 2032 (USD Million)
8.3.3 Market size, by indication, 2018 – 2032 (USD Million)
8.3.4 Market size, by end-use, 2018 – 2032 (USD Million)
8.3.5 Germany
8.3.5.1 Market size, by diagnostics & therapy, 2018 – 2032 (USD Million)
8.3.5.1.1 Market size, by diagnostics, 2018 - 2032 (USD Million)
8.3.5.1.2 Market size, by therapy, 2018 - 2032 (USD Million)
8.3.5.1.2.1 Market size, by non-invasive, 2018 - 2032 (USD Million)
8.3.5.1.2.2 Market size, by minimally invasive, 2018 - 2032 (USD Million)
8.3.5.2 Market size, by indication, 2018 – 2032 (USD Million)
8.3.5.3 Market size, by end-use, 2018 – 2032 (USD Million)
8.3.6 UK
8.3.6.1 Market size, by diagnostics & therapy, 2018 – 2032 (USD Million)
8.3.6.1.1 Market size, by diagnostics, 2018 - 2032 (USD Million)
8.3.6.1.2 Market size, by therapy, 2018 - 2032 (USD Million)
8.3.6.1.2.1 Market size, by non-invasive, 2018 - 2032 (USD Million)
8.3.6.1.2.2 Market size, by minimally invasive, 2018 - 2032 (USD Million)
8.3.6.2 Market size, by indication, 2018 – 2032 (USD Million)
8.3.6.3 Market size, by end-use, 2018 – 2032 (USD Million)
8.3.7 France
8.3.7.1 Market size, by diagnostics & therapy, 2018 – 2032 (USD Million)
8.3.7.1.1 Market size, by diagnostics, 2018 - 2032 (USD Million)
8.3.7.1.2 Market size, by therapy, 2018 - 2032 (USD Million)
8.3.7.1.2.1 Market size, by non-invasive, 2018 - 2032 (USD Million)
8.3.7.1.2.2 Market size, by minimally invasive, 2018 - 2032 (USD Million)
8.3.7.2 Market size, by indication, 2018 – 2032 (USD Million)
8.3.7.3 Market size, by end-use, 2018 – 2032 (USD Million)
8.3.8 Italy
8.3.8.1 Market size, by diagnostics & therapy, 2018 – 2032 (USD Million)
8.3.8.1.1 Market size, by diagnostics, 2018 - 2032 (USD Million)
8.3.8.1.2 Market size, by therapy, 2018 - 2032 (USD Million)
8.3.8.1.2.1 Market size, by non-invasive, 2018 - 2032 (USD Million)
8.3.8.1.2.2 Market size, by minimally invasive, 2018 - 2032 (USD Million)
8.3.8.2 Market size, by indication, 2018 – 2032 (USD Million)
8.3.8.3 Market size, by end-use, 2018 – 2032 (USD Million)
8.3.9 Spain
8.3.9.1 Market size, by diagnostics & therapy, 2018 – 2032 (USD Million)
8.3.9.1.1 Market size, by diagnostics, 2018 - 2032 (USD Million)
8.3.9.1.2 Market size, by therapy, 2018 - 2032 (USD Million)
8.3.9.1.2.1 Market size, by non-invasive, 2018 - 2032 (USD Million)
8.3.9.1.2.2 Market size, by minimally invasive, 2018 - 2032 (USD Million)
8.3.9.2 Market size, by indication, 2018 – 2032 (USD Million)
8.3.9.3 Market size, by end-use, 2018 – 2032 (USD Million)
8.4 Asia Pacific
8.4.1 Market size, by country, 2018 – 2032 (USD Million)
8.4.2 Market size, by diagnostics & therapy, 2018 – 2032 (USD Million)
8.4.2.1 Market size, by diagnostics, 2018 - 2032 (USD Million)
8.4.2.2 Market size, by therapy, 2018 - 2032 (USD Million)
8.4.2.2.1 Market size, by non-invasive, 2018 - 2032 (USD Million)
8.4.2.2.2 Market size, by minimally invasive, 2018 - 2032 (USD Million)
8.4.3 Market size, by indication, 2018 – 2032 (USD Million)
8.4.4 Market size, by end-use, 2018 – 2032 (USD Million)
8.4.5 China
8.4.5.1 Market size, by diagnostics & therapy, 2018 – 2032 (USD Million)
8.4.5.1.1 Market size, by diagnostics, 2018 - 2032 (USD Million)
8.4.5.1.2 Market size, by therapy, 2018 - 2032 (USD Million)
8.4.5.1.2.1 Market size, by non-invasive, 2018 - 2032 (USD Million)
8.4.5.1.2.2 Market size, by minimally invasive, 2018 - 2032 (USD Million)
8.4.5.2 Market size, by indication, 2018 – 2032 (USD Million)
8.4.5.3 Market size, by end-use, 2018 – 2032 (USD Million)
8.4.6 Japan
8.4.6.1 Market size, by diagnostics & therapy, 2018 – 2032 (USD Million)
8.4.6.1.1 Market size, by diagnostics, 2018 - 2032 (USD Million)
8.4.6.1.2 Market size, by therapy, 2018 - 2032 (USD Million)
8.4.6.1.2.1 Market size, by non-invasive, 2018 - 2032 (USD Million)
8.4.6.1.2.2 Market size, by minimally invasive, 2018 - 2032 (USD Million)
8.4.6.2 Market size, by indication, 2018 – 2032 (USD Million)
8.4.6.3 Market size, by end-use, 2018 – 2032 (USD Million)
8.4.7 India
8.4.7.1 Market size, by diagnostics & therapy, 2018 – 2032 (USD Million)
8.4.7.1.1 Market size, by diagnostics, 2018 - 2032 (USD Million)
8.4.7.1.2 Market size, by therapy, 2018 - 2032 (USD Million)
8.4.7.1.2.1 Market size, by non-invasive, 2018 - 2032 (USD Million)
8.4.7.1.2.2 Market size, by minimally invasive, 2018 - 2032 (USD Million)
8.4.7.2 Market size, by indication, 2018 – 2032 (USD Million)
8.4.7.3 Market size, by end-use, 2018 – 2032 (USD Million)
8.4.8 Australia
8.4.8.1 Market size, by diagnostics & therapy, 2018 – 2032 (USD Million)
8.4.8.1.1 Market size, by diagnostics, 2018 - 2032 (USD Million)
8.4.8.1.2 Market size, by therapy, 2018 - 2032 (USD Million)
8.4.8.1.2.1 Market size, by non-invasive, 2018 - 2032 (USD Million)
8.4.8.1.2.2 Market size, by minimally invasive, 2018 - 2032 (USD Million)
8.4.8.2 Market size, by indication, 2018 – 2032 (USD Million)
8.4.8.3 Market size, by end-use, 2018 – 2032 (USD Million)
8.5 Latin America
8.5.1 Market size, by country, 2018 – 2032 (USD Million)
8.5.2 Market size, by diagnostics & therapy, 2018 – 2032 (USD Million)
8.5.2.1 Market size, by diagnostics, 2018 - 2032 (USD Million)
8.5.2.2 Market size, by therapy, 2018 - 2032 (USD Million)
8.5.2.2.1 Market size, by non-invasive, 2018 - 2032 (USD Million)
8.5.2.2.2 Market size, by minimally invasive, 2018 - 2032 (USD Million)
8.5.3 Market size, by indication, 2018 – 2032 (USD Million)
8.5.4 Market size, by end-use, 2018 – 2032 (USD Million)
8.5.5 Brazil
8.5.5.1 Market size, by diagnostics & therapy, 2018 – 2032 (USD Million)
8.5.5.1.1 Market size, by diagnostics, 2018 - 2032 (USD Million)
8.5.5.1.2 Market size, by therapy, 2018 - 2032 (USD Million)
8.5.5.1.2.1 Market size, by non-invasive, 2018 - 2032 (USD Million)
8.5.5.1.2.2 Market size, by minimally invasive, 2018 - 2032 (USD Million)
8.5.5.2 Market size, by indication, 2018 – 2032 (USD Million)
8.5.5.3 Market size, by end-use, 2018 – 2032 (USD Million)
8.5.6 Mexico
8.5.6.1 Market size, by diagnostics & therapy, 2018 – 2032 (USD Million)
8.5.6.1.1 Market size, by diagnostics, 2018 - 2032 (USD Million)
8.5.6.1.2 Market size, by therapy, 2018 - 2032 (USD Million)
8.5.6.1.2.1 Market size, by non-invasive, 2018 - 2032 (USD Million)
8.5.6.1.2.2 Market size, by minimally invasive, 2018 - 2032 (USD Million)
8.5.6.2 Market size, by indication, 2018 – 2032 (USD Million)
8.5.6.3 Market size, by end-use, 2018 – 2032 (USD Million)
8.5.7 Argentina
8.5.7.1 Market size, by diagnostics & therapy, 2018 – 2032 (USD Million)
8.5.7.1.1 Market size, by diagnostics, 2018 - 2032 (USD Million)
8.5.7.1.2 Market size, by therapy, 2018 - 2032 (USD Million)
8.5.7.1.2.1 Market size, by non-invasive, 2018 - 2032 (USD Million)
8.5.7.1.2.2 Market size, by minimally invasive, 2018 - 2032 (USD Million)
8.5.7.2 Market size, by indication, 2018 – 2032 (USD Million)
8.5.7.3 Market size, by end-use, 2018 – 2032 (USD Million)
8.6 MEA
8.6.1 Market size, by country, 2018 – 2032 (USD Million)
8.6.2 Market size, by diagnostics & therapy, 2018 – 2032 (USD Million)
8.6.2.1 Market size, by diagnostics, 2018 - 2032 (USD Million)
8.6.2.2 Market size, by therapy, 2018 - 2032 (USD Million)
8.6.2.2.1 Market size, by non-invasive, 2018 - 2032 (USD Million)
8.6.2.2.2 Market size, by minimally invasive, 2018 - 2032 (USD Million)
8.6.3 Market size, by indication, 2018 – 2032 (USD Million)
8.6.4 Market size, by end-use, 2018 – 2032 (USD Million)
8.6.5 South Africa
8.6.5.1 Market size, by diagnostics & therapy, 2018 – 2032 (USD Million)
8.6.5.1.1 Market size, by diagnostics, 2018 - 2032 (USD Million)
8.6.5.1.2 Market size, by therapy, 2018 - 2032 (USD Million)
8.6.5.1.2.1 Market size, by non-invasive, 2018 - 2032 (USD Million)
8.6.5.1.2.2 Market size, by minimally invasive, 2018 - 2032 (USD Million)
8.6.5.2 Market size, by indication, 2018 – 2032 (USD Million)
8.6.5.3 Market size, by end-use, 2018 – 2032 (USD Million)
8.6.6 Saudi Arabia
8.6.6.1 Market size, by diagnostics & therapy, 2018 – 2032 (USD Million)
8.6.6.1.1 Market size, by diagnostics, 2018 - 2032 (USD Million)
8.6.6.1.2 Market size, by therapy, 2018 - 2032 (USD Million)
8.6.6.1.2.1 Market size, by non-invasive, 2018 - 2032 (USD Million)
8.6.6.1.2.2 Market size, by minimally invasive, 2018 - 2032 (USD Million)
8.6.6.2 Market size, by indication, 2018 – 2032 (USD Million)
8.6.6.3 Market size, by end-use, 2018 – 2032 (USD Million)
8.6.7 UAE
8.6.7.1 Market size, by diagnostics & therapy, 2018 – 2032 (USD Million)
8.6.7.1.1 Market size, by diagnostics, 2018 - 2032 (USD Million)
8.6.7.1.2 Market size, by therapy, 2018 - 2032 (USD Million)
8.6.7.1.2.1 Market size, by non-invasive, 2018 - 2032 (USD Million)
8.6.7.1.2.2 Market size, by minimally invasive, 2018 - 2032 (USD Million)
8.6.7.2 Market size, by indication, 2018 – 2032 (USD Million)
8.6.7.3 Market size, by end-use, 2018 – 2032 (USD Million)
Chapter 9 Company Profiles
9.1 F. Hoffmann-La Roche
9.1.1 Business overview
9.1.2 Financial data
9.1.3 Service landscape
9.1.4 SWOT analysis
9.2 AstraZeneca
9.2.1 Business overview
9.2.2 Financial data
9.2.3 Service landscape
9.2.4 SWOT analysis
9.3 Sanofi
9.3.1 Business overview
9.3.2 Financial data
9.3.3 Service landscape
9.3.4 SWOT analysis
9.4 Pfizer, Inc.
9.4.1 Business overview
9.4.2 Financial data
9.4.3 Service landscape
9.4.4 SWOT analysis
9.5 Bristol-Myers Squibb Company
9.5.1 Business overview
9.5.2 Financial data
9.5.3 Service landscape
9.5.4 SWOT analysis
9.6 Sysmex Corporation
9.6.1 Business overview
9.6.2 Financial data
9.6.3 Service landscape
9.6.4 SWOT analysis
9.7 Thermo Fischer Scientific
9.7.1 Business overview
9.7.2 Financial data
9.7.3 Service landscape
9.7.4 SWOT analysis
9.8 Qiagen
9.8.1 Business overview
9.8.2 Financial data
9.8.3 Service landscape
9.8.4 SWOT analysis
9.9 Janssen Pharmaceuticals
9.9.1 Business overview
9.9.2 Financial data
9.9.3 Service landscape
9.9.4 SWOT analysis
9.10 Quest Diagnostics
9.10.1 Business overview
9.10.2 Financial data
9.10.3 Service landscape
9.10.4 SWOT analysis
9.11 Takeda Pharmaceutical Company
9.11.1 Business overview
9.11.2 Financial data
9.11.3 Service landscape
9.11.4 SWOT analysis
9.12 Novartis AG.
9.12.1 Business overview
9.12.2 Financial data
9.12.3 Service landscape
9.12.4 SWOT analysis
9.13 Eli Lilly & Company (Lilly)
9.13.1 Business overview
9.13.2 Financial data
9.13.3 Service landscape
9.13.4 SWOT analysis
9.14 Merck & Co. Inc.
9.14.1 Business overview
9.14.2 Financial data
9.14.3 Service landscape
9.14.4 SWOT analysis
